The clinical aspects of pituitary tumour genetics

Pituitary tumours are usually benign and relatively common intracranial tumours, with under- and overexpression of pituitary hormones and local mass effects causing considerable morbidity and increased mortality. While most pituitary tumours are sporadic, around 5% of the cases arise in a familial setting, either isolated [familial isolated pituitary adenoma, related to AIP or X-linked acrogigantism], or in a syndromic disorder, such as multiple endocrine neoplasia type 1 or 4, Carney complex, McCune–Albright syndrome, phaeochromocytoma/paraganglioma with pituitary adenoma, DICER1 syndrome, Lynch syndrome, and USP8-related syndrome. Genetically determined pituitary tumours usually present at younger age and show aggressive behaviour, and are often resistant to different treatment modalities.

Overview publication

TytułThe clinical aspects of pituitary tumour genetics
Data4 lutego, 2021
Nazwa wydaniaEndocrine
Numer wydania2021(2)
AutorzyDénes J & Korbonits M
Read Read publication
 Ten tekst nie jest dostępny w polski